ivabradine has been researched along with sildenafil citrate in 2 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 5,862 | 956 | 2,319 |
| Protein | Taxonomy | ivabradine (IC50) | sildenafil citrate (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunetti, ND; Correale, M; Di Biase, M; Ieva, R; Montrone, D | 1 |
| Gabrielsson, J; Jirstrand, M; Martel, E; Pairet, N; Scheuerer, S; Wallman, M | 1 |
2 other study(ies) available for ivabradine and sildenafil citrate
| Article | Year |
|---|---|
Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
Topics: Aged; Antihypertensive Agents; Arterial Pressure; Benzazepines; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Ivabradine; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prostaglandins; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2013 |
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data.
Topics: Animals; Biomarkers, Pharmacological; Blood Pressure; Cardiotoxicity; Cardiovascular Agents; Heart Rate; Ivabradine; Male; Phenethylamines; Pyridazines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides | 2021 |